MANATT, PHELPS, AND PHILLIPS

Lobbying for DENALI THERAPEUTICS · Biopharmaceutical Company

Filing 2nd Quarter - Report (No Activity)

2nd Quarter (Apr 1 - June 30) 2026 · California · $70,000.00 income · posted Jul 14, 2026

Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem